BioCryst Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 08:30PM GMT
Maury Raycroft - Jefferies LLC - Analyst

Hi, everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to introduce our guests today, Jon Stonehouse, the President and CEO of BioCryst and also John Bluth is with us as well. We're going to do fireside chat format. Thanks for joining us today.

Questions and Answers:

Maury Raycroft - Jefferies LLC - Analyst

And maybe to start off, if Jon, you want to give a one minute intro to BioCryst?

Jon Stonehouse - BioCryst Pharmaceuticals, Inc. - President & CEO

Sure. Thanks, Maury, for inviting us in -- inviting us to your healthcare conference. So we're a company that develops -- discovers and develops, and commercializes small molecules for patients suffering from rare disease to give them the opportunity to have an oral drug. And it's a big deal for patients. It's not some incremental convenience improvement if they can take a once-a-day capsule. It has the effect of being like a daily vitamin and they forget their sex. They're
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot